Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00249756 · ClinicalTrials.gov registry record · NA
Re-Entry MTC for Offenders With MICA Disorders
A NA study, sponsored by National Development and Research Institutes.
- Completed
- Registry status
- NA
- Development phase
- 610
- Enrollment target
NCT00249756: Completed NA study, sponsored by National Development and Research Institutes.
NCT00249756 is a NA study that has completed, run by National Development and Research Institutes. The registered enrollment target is 610 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00249756, a NA study, has completed, sponsored by National Development and Research Institutes.
- COMPLETED
- Registry status
- NA
- Development phase
- 610 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the transition of offenders with both mental illness and chemical abuse (MICA) disorders from prison to the community, where continued treatment is generally considered necessary to sustain gains made by prison treatment, and to achieve successful outcomes. The project will determine the effectiveness of a modified therapeutic community (Re-Entry MTC) approach as compared to the case management and parole supervision currently provided. The study will also assess the relative impact on treatment outcomes of the type of treatment received while in prison and of the progress achieved in re-entry treatment.
Primary Outcome
The CTCR Protocol (CTCR, 1992) is a structured interview adapted from the ASI and DATAR for use in community treatment and the criminal justice system. The CTCR Protocol assesses these domains: socio-demographic background, substance use, psychosocial functioning, criminal justice involvement, education, employment, parenting, peer and family relations, and health. Measures of independent living skills and community functioning will be added.
Interventions
- BEHAVIORAL Re-entry Modified Therapeutic Community (Re-entry MTC)
- BEHAVIORAL Parole Supervision and Case Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2005-08 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT00249756 record still lists
NCT00249756 is an interventional study that assigns participants to a tested intervention. The registered 610 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Re-entry Modified Therapeutic Community (Re-entry MTC) is the first listed.
NCT00249756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00249756 about?
NCT00249756 is a clinical study titled "Re-Entry MTC for Offenders With MICA Disorders". The purpose of this study is to examine the transition of offenders with both mental illness and chemical abuse (MICA) disorders from prison to the community, where continued treatment is generally considered necessary to sustain gains made by prison treatment, and to achieve successful outcomes. Th...
What is the current status of trial NCT00249756?
This trial is currently completed. It is a NA study. The enrollment target is 610 participants. The study started on 2005-08. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00249756?
The interventions under investigation include: Re-entry Modified Therapeutic Community (Re-entry MTC) (BEHAVIORAL), Parole Supervision and Case Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00249756?
This trial is sponsored by National Development and Research Institutes, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00249756's enrollment target sits among peer trials
610 161st of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03536312 · 610 participants · NA
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- NCT05838638 · 610 participants · NA
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
- NCT07075718 · 610 participants · Phase 2
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia